血型鑑定市场 - 全球产业规模、份额、趋势、机会及预测（按产品、技术、检测类型、最终用户、地区和竞争格局划分，2021-2031年）

全球血型鑑定市场预计将从 2025 年的 24.2 亿美元成长到 2031 年的 40.5 亿美元，复合年增长率达到 8.94%。

血型鑑定是一种诊断程序，用于识别红血球上的特定ABO和Rh抗原，以确保输血前的血清学相容性。该市场的主要成长要素是全球慢性血液疾病盛行率的上升以及需要即时输血的创伤病例的增加。此外，越来越多的复杂外科手术需要严格的输血前筛检以确保病患安全，这持续推动医疗机构对精准血型鑑定试剂和自动化检测系统的强劲需求。

然而，由于血液供应不稳定，市场面临许多重大障碍，阻碍了检测流程的顺利进行。捐血数量的下降给库存管理带来了巨大压力，导致频繁的供不应求，难以有效利用血型鑑定资源。例如，美国红十字会报告称，由于持续的捐血短缺，2024年7月全国血液库存下降了超过25%。这种供应链的不稳定性造成了营运方面的挑战，可能会阻碍血型鑑定市场的稳定成长。

市场驱动因素

自动化和分子血型鑑定解决方案的技术创新正在从根本上重塑市场格局，显着提升诊断准确性和营运效率。检查室正日益从人工操作转向全自动平台，最大限度地减少人为误差，并实现ABO/Rh血型鑑定结果的标准化。这一转变在关键诊断系统主要供应商的财务表现中得到了清晰的体现。例如，Grifols在2025年2月发布的「2024财年全年业绩报告」中指出，其血型鑑定解决方案部门在主要国际市场实现了两位数的成长。这一快速成长主要归功于自动化设备的加速普及。这些技术不仅提高了处理速度，还提供了大型血站维持稳定工作流程所需的高通量处理能力。

同时，需要输血的创伤病例的增加正成为市场扩张的主要驱动力。在急诊室中，快速且准确的血型鑑定对于预防在救命手术过程中发生致命的输血反应至关重要。血型鑑定试剂的需求与创伤中心收治的需要大量输血的患者数量直接相关。正如美国红十字会在其2025年5月发布的「创伤季捐血」新闻稿中所述，约25%的创伤患者需要输血，这使得对相容性血液製品的需求变得迫切。这种持续的临床需求支撑着耗材产业的稳定。例如，Quidel Orso在其2025年2月发布的「2024财年第四季及全年财务表现」中强调，其输血医学业务在2024年实现了超过90%的经常性收入增长，这证实了血型鑑定在现代医学中不可或缺的重要性。

市场挑战

血液供应的持续不稳定对血型鑑定市场构成重大限制，因为它直接限制了可进行的诊断检测数量。随着捐血人数的下降，血站和医院立即面临库存短缺，迫使他们减少输血前检测的数量。这种直接关联导致捐血数量减少，进而导致检测试剂和自动化检测平台的使用率降低。因此，检查室无法维持稳定的侦测量，导致设备运转率下降，以及必要的诊断耗材采购频率降低。

这些供应链中断造成了营运不稳定，阻碍了长期市场规划和扩张。捐血参与度的不确定性迫使医疗机构保守地管理库存，限制了血型鑑定产品的稳定消耗。例如，2024年7月，英国国家医疗服务体系（NHS）血液和移植服务中心报告称，全国O型Rh阴性血的库存已降至仅够1.6天使用，迫使临床人员将其使用限制在紧急情况下。如此严重的短缺降低了对血型鑑定服务的整体需求，阻碍了产业发展所需的持续产生收入，从而抑制了市场成长。

市场趋势

人们对客製化检测以识别罕见血型越来越感兴趣，尤其关注那些需要精确表型匹配的长期输血患者的需求。在镰状细胞疾病等复杂病例中，标准的血清学检测往往不足以预防同种免疫，因此需要广泛的捐血筛检计画。这种临床转变使血站能够更有效地管理多样化的血库，并确保难以匹配的受血者获得匹配的血液。根据美国红十字会2025年9月「镰状细胞疾病宣传月」的新闻稿，该组织进行了超过30万次镰状细胞携带者筛检，这表明对这种精准检测的需求日益增长，因为它是识别具有罕见抗原谱的匹配捐血者的关键措施。

同时，人类白血球抗原（HLA）分型应用范围的不断扩大，也使血型鑑定市场更加多元化。实验室正拓展其诊断能力，不再局限于传统的红血球抗原检测，而是利用先进的基因组平台，为器官和干细胞移植提供组织分型，实现高解析度匹配。将移植诊断整合到血库工作流程中，标誌着血库在支持复杂临床干预方面，策略性地扩展了服务范围。正如Wharfen在2025年3月发布的《2024年非财务资讯报告》中所述，该公司专业的移植部门占据了12%的市场份额，这反映出业界对专业分型解决方案的日益重视。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球血型鑑定市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品（耗材、设备、服务）分类
  • 依技术分类（基于PCR和微阵列的技术、基于检测的技术、大规模平行定定序等）
  • 依检测类型（抗体筛检、 HLA型检测、ABO血型检测、交叉配对试验血、抗原分型）
  • 依最终使用者（医院、临床检查室、血库、其他最终使用者）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美血型鑑定市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲血型鑑定市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章 亚太地区血型鑑定市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章 中东和非洲血型鑑定市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章 南美洲血型鑑定市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球血型鑑定市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Illumina, Inc.
• Immucor, Inc.
• CareDx Inc.
• Mesa Laboratories, Inc.
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• AliveDx Suisse SA
• QuidelOrtho Corporation

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Blood Group Typing Market is projected to expand from USD 2.42 Billion in 2025 to USD 4.05 Billion by 2031, achieving a CAGR of 8.94%. Blood group typing is a diagnostic procedure utilized to identify specific ABO and Rh antigens on red blood cells, ensuring serological compatibility before transfusion. The market is primarily driven by the increasing global prevalence of chronic hematologic disorders and a rising number of trauma cases that necessitate immediate blood replacement. Additionally, the growing volume of complex surgical procedures requires rigorous pre-transfusion screening to ensure patient safety, thereby sustaining strong demand for accurate typing reagents and automated assay systems across healthcare facilities.

However, the market encounters significant obstacles due to the volatility of blood supplies, which disrupts consistent testing workflows. A declining donor base places immense pressure on inventory management, frequently resulting in supply shortages that complicate the efficient use of typing resources. For example, the American Red Cross reported that the national blood inventory fell by more than 25 percent in July 2024 due to persistent donor shortages. This instability in the supply chain creates operational challenges that can impede the steady growth of the blood group typing market.

Market Driver

Technological innovations in automated and molecular blood typing solutions are fundamentally reshaping the market by improving diagnostic precision and operational efficiency. Laboratories are increasingly transitioning from manual methods to fully automated platforms, which minimize human error and standardize ABO/Rh typing results. This shift is financially evident in the performance of major industry players supplying these critical diagnostic systems. For instance, Grifols reported in their 'Full Year 2024 Results' in February 2025 that their Blood Typing Solutions division achieved double-digit growth in key international markets, a surge largely attributed to the accelerated adoption of these automated instruments. Such technologies not only enhance speed but also provide the high-volume processing capabilities necessary for maintaining steady workflows in large-scale blood centers.

Simultaneously, the rising incidence of trauma cases requiring transfusion acts as a primary catalyst for market expansion. Emergency medicine depends heavily on immediate and precise blood grouping to prevent fatal transfusion reactions during critical care interventions. The demand for typing reagents correlates directly with the volume of patients entering trauma centers who require substantial blood support. As noted by the American Red Cross in their May 2025 'Trauma Season Blood Donation' press release, approximately 25 percent of all trauma patients require blood transfusions, driving an urgent need for compatible blood products. This consistent clinical demand underpins the stability of the consumables sector; for example, QuidelOrtho highlighted in their February 2025 'Q4 and Full Year 2024 Financial Results' that the company's Transfusion Medicine business achieved over 90 percent recurring revenue in 2024, underscoring the essential nature of blood typing in modern healthcare.

Market Challenge

The persistent volatility of blood supplies functions as a substantial restraint on the blood group typing market by directly limiting the volume of diagnostic procedures performed. When donor participation declines, blood centers and hospitals face immediate inventory deficits, necessitating a reduction in the number of pre-transfusion tests conducted. This direct correlation means that a shrinking donor base results in lower utilization rates for typing reagents and automated assay platforms. Consequently, laboratories are unable to maintain consistent testing throughput, leading to idle equipment capacity and a reduced frequency of procurement for essential diagnostic consumables.

These supply chain disruptions introduce operational instability that hinders long-term market planning and expansion. The unpredictability of donor turnout forces healthcare facilities to manage inventories conservatively, restricting the steady consumption of typing products. For instance, NHS Blood and Transplant reported in July 2024 that national stocks of O Negative blood dropped to just 1.6 days, requiring clinical staff to restrict usage to emergency cases. Such critical shortages stall market growth by lowering the overall demand for typing services and preventing the continuous revenue generation necessary for industry development.

Market Trends

There is a growing focus on customized assays for rare blood group identification, prioritizing the needs of chronically transfused patients who require precise phenotypic matching. Standard serological tests are often insufficient for preventing alloimmunization in complex cases, such as those involving sickle cell disease, prompting the adoption of extensive donor screening programs. This clinical shift enables blood centers to manage diverse inventories more effectively and ensure compatibility for recipients who are difficult to match. According to the American Red Cross's September 2025 'Sickle Cell Awareness Month' press release, the organization supported this demand for precision by providing more than 300,000 sickle cell trait screenings, a critical measure for identifying compatible donors with rare antigen profiles.

Concurrently, the expansion of Human Leukocyte Antigen (HLA) typing applications is diversifying the operational scope of the blood group typing market. Laboratories are extending their diagnostic capabilities beyond traditional red cell antigens to include histocompatibility testing for organ and stem cell transplantation, utilizing advanced genomic platforms for high-resolution matching. This integration of transplant diagnostics into blood bank workflows represents a strategic broadening of services to support complex clinical interventions. As noted by Werfen in their March 2025 'Non-Financial Information Statement for 2024', the company's dedicated Transplant division secured a 12 percent share of the market, reflecting the increasing industrial emphasis on these specialized typing solutions.

Key Market Players

• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Illumina, Inc.
• Immucor, Inc.
• CareDx Inc.
• Mesa Laboratories, Inc.
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• AliveDx Suisse SA
• QuidelOrtho Corporation

Report Scope

In this report, the Global Blood Group Typing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Group Typing Market, By Product

• Consumables
• Instruments
• Services

Blood Group Typing Market, By Technique

• PCR-Based and Microarray Techniques
• Assay-Based Techniques
• Massively Parallel Sequencing
• Others

Blood Group Typing Market, By Test Type

• Antibody Screening
• HLA Typing
• ABO Blood Tests
• Cross-Matching Tests
• Antigen Typing

Blood Group Typing Market, By End User

• Hospitals
• Clinical Laboratories
• Blood Banks
• Other End Users

Blood Group Typing Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Group Typing Market.

Available Customizations:

Global Blood Group Typing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blood Group Typing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Consumables, Instruments, Services)
  • 5.2.2. By Technique (PCR-Based and Microarray Techniques, Assay-Based Techniques, Massively Parallel Sequencing, Others)
  • 5.2.3. By Test Type (Antibody Screening, HLA Typing, ABO Blood Tests, Cross-Matching Tests, Antigen Typing)
  • 5.2.4. By End User (Hospitals, Clinical Laboratories, Blood Banks, Other End Users)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Blood Group Typing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technique
  • 6.2.3. By Test Type
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Blood Group Typing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technique
      • 6.3.1.2.3. By Test Type
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Blood Group Typing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technique
      • 6.3.2.2.3. By Test Type
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Blood Group Typing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technique
      • 6.3.3.2.3. By Test Type
      • 6.3.3.2.4. By End User

7. Europe Blood Group Typing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technique
  • 7.2.3. By Test Type
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Blood Group Typing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technique
      • 7.3.1.2.3. By Test Type
      • 7.3.1.2.4. By End User
  • 7.3.2. France Blood Group Typing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technique
      • 7.3.2.2.3. By Test Type
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Blood Group Typing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technique
      • 7.3.3.2.3. By Test Type
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Blood Group Typing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technique
      • 7.3.4.2.3. By Test Type
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Blood Group Typing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technique
      • 7.3.5.2.3. By Test Type
      • 7.3.5.2.4. By End User

8. Asia Pacific Blood Group Typing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technique
  • 8.2.3. By Test Type
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Blood Group Typing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technique
      • 8.3.1.2.3. By Test Type
      • 8.3.1.2.4. By End User
  • 8.3.2. India Blood Group Typing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technique
      • 8.3.2.2.3. By Test Type
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Blood Group Typing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technique
      • 8.3.3.2.3. By Test Type
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Blood Group Typing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technique
      • 8.3.4.2.3. By Test Type
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Blood Group Typing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technique
      • 8.3.5.2.3. By Test Type
      • 8.3.5.2.4. By End User

9. Middle East & Africa Blood Group Typing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technique
  • 9.2.3. By Test Type
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Blood Group Typing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technique
      • 9.3.1.2.3. By Test Type
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Blood Group Typing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technique
      • 9.3.2.2.3. By Test Type
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Blood Group Typing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technique
      • 9.3.3.2.3. By Test Type
      • 9.3.3.2.4. By End User

10. South America Blood Group Typing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technique
  • 10.2.3. By Test Type
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Blood Group Typing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technique
      • 10.3.1.2.3. By Test Type
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Blood Group Typing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technique
      • 10.3.2.2.3. By Test Type
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Blood Group Typing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technique
      • 10.3.3.2.3. By Test Type
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Blood Group Typing Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Danaher Corporation
• 15.3. Illumina, Inc.
• 15.4. Immucor, Inc.
• 15.5. CareDx Inc.
• 15.6. Mesa Laboratories, Inc.
• 15.7. Bio-Rad Laboratories, Inc.
• 15.8. Merck KGaA
• 15.9. AliveDx Suisse SA
• 15.10. QuidelOrtho Corporation

16. Strategic Recommendations

17. About Us & Disclaimer